We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange (ECLIPSE)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00932087
First Posted: July 2, 2009
Last Update Posted: April 13, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hospices Civils de Lyon
  Purpose
Case control design: lipidomic study in 12 type 2 diabetics with metabolic syndrome, 12 metabolic syndrome without diabetes, 12 subjects with type 1 diabetes and 12 controls

Condition Intervention
Diabetes Metabolic Syndrome Procedure: Blood sample

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange

Resource links provided by NLM:


Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:
  • Level of plasma isoprostane and lipoperoxides [ Time Frame: at baseline ]

Secondary Outcome Measures:
  • TXA2 and PF4 levels after platelet activation of control platelet exposed to LDL [ Time Frame: 2 hours ]

Estimated Enrollment: 48
Study Start Date: February 2009
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
type 2 diabetics with metabolic syndrome Procedure: Blood sample
Blood sample for lipidomic study
metabolic syndrome without diabetes Procedure: Blood sample
Blood sample for lipidomic study
type 1 diabetes Procedure: Blood sample
Blood sample for lipidomic study
control Procedure: Blood sample
Blood sample for lipidomic study

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
group 1: type 2 diabetics with metabolic syndrome group 2: metabolic syndrome without diabetes group 3: subjects with type 1 diabetes group 4: controls
Criteria

Inclusion Criteria:

  • statin and fibrate Wash out for one week
  • HbA1c>7% and <12% (Arms 1 and 3)
  • HbA1c<6% (Arms 2 and 4)
  • Metabolic sd according NCEP III (3 out 4 criteria) (Arms 1 and 2)

Exclusion Criteria:

  • secondary CV prevention
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00932087


Locations
France
Fédération d'Endocrinologie-Diabétologie-Maladies métaboliques-Nutrition - Hôpital Cardiovasculaire et Pneumologique
Lyon Cedex 03, France, 69394
Sponsors and Collaborators
Hospices Civils de Lyon
Investigators
Principal Investigator: Philippe MOULIN, MD, PhD Hospices Civils de Lyon
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Philippe MOULIN, MD PhD, Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT00932087     History of Changes
Other Study ID Numbers: 2008.516
First Submitted: June 22, 2009
First Posted: July 2, 2009
Last Update Posted: April 13, 2010
Last Verified: April 2010

Keywords provided by Hospices Civils de Lyon:
Platelet function
diabetes
metabolic syndrome

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases